Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1996-4-4
|
| pubmed:abstractText |
Aiming at a safe method in the diagnosis of aluminium-related bone disease (ARBD)/aluminium overload the low-dose desferrioxamine (DFO) test was developed. In a multicentre study histological and histochemical data and aluminium bulk analysis of bone biopsies of 77 dialysis patients were correlated with the results of both the 5 mg/kg and 10 mg/kg DFO tests.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0931-0509
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1874-84
|
| pubmed:dateRevised |
2010-3-24
|
| pubmed:meshHeading |
pubmed-meshheading:8592597-Adult,
pubmed-meshheading:8592597-Aged,
pubmed-meshheading:8592597-Aluminum,
pubmed-meshheading:8592597-Bone Diseases,
pubmed-meshheading:8592597-Deferoxamine,
pubmed-meshheading:8592597-Dose-Response Relationship, Drug,
pubmed-meshheading:8592597-Female,
pubmed-meshheading:8592597-Humans,
pubmed-meshheading:8592597-Male,
pubmed-meshheading:8592597-Middle Aged,
pubmed-meshheading:8592597-Pilot Projects,
pubmed-meshheading:8592597-Predictive Value of Tests,
pubmed-meshheading:8592597-Risk Factors,
pubmed-meshheading:8592597-Sensitivity and Specificity
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.
|
| pubmed:affiliation |
Department of Nephrology-Hypertension, University of Antwerp, Belgium.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|